3 Green Flags for Pfizer's Future
COVID-19 is both contagious and deadly, and when a vaccine becomes available, billions of people worldwide may need to take it if economies are to reopen safely. This creates a gigantic opportunity for any company that can create an effective coronavirus vaccine.
Since the stock prices of many vaccine makers have already gone up a lot this year, investors may worry about buying at artificially high prices. But Pfizer (NYSE: PFE) remains quite undervalued given its potential blockbuster vaccine candidate, which it's researching jointly with Germany-based BioNTech (NASDAQ: BNTX).
Let's look at three reasons long-term value investors should snatch up some Pfizer shares right now to be a part of its bright future.
Source Fool.com
